Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

BACKGROUND: The potential for cancer-testis (CT) antigens as targets for immunotherapy in cancer patients has been heavily investigated, and currently cancer vaccine trials based on the CT antigens, MAGE-A3 and NY-ESO-1, are being carried out. METHODS: We used specific q-RT-PCR assays to analyse the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyrskjøt, L, Zieger, K, Kissow Lildal, T, Reinert, T, Gruselle, O, Coche, T, Borre, M, Ørntoft, T F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389414/
https://www.ncbi.nlm.nih.gov/pubmed/22596240
http://dx.doi.org/10.1038/bjc.2012.215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389414/
https://www.ncbi.nlm.nih.gov/pubmed/22596240
http://dx.doi.org/10.1038/bjc.2012.215

Ejemplares similares